Current position

Ray Dalio’s Thermo Fisher Scientific Inc (TMO) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2007Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares276.57KHighest verified quarter-end share count
Quarters reported30Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Thermo Fisher Scientific Inc in Q1 2007. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Bridgewater Associates, LP currently reports 12.95K shares. The latest verified filing showed: Sold 10.6% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 10.6% of the position−1.54K shares · 12.95K shares remained
Filing context

Quarter-end price $501.36 · Estimated holding basis $501.76

Q1 2026
Bought 759.3% more+12.80K shares · 14.49K shares reported after the change
Filing context

Quarter-end price $491.53 · Estimated holding basis $501.76

Q4 2025
New position+1.69K shares · 1.69K shares reported
Filing context

Quarter-end price $579.45 · Estimated holding basis $579.45

Q3 2024
Sold the entire position−33.73K shares · No shares reported at quarter-end
Q2 2024
New position+33.73K shares · 33.73K shares reported
Filing context

Quarter-end price $553.00 · Estimated holding basis $553.00

Q4 2023
Sold the entire position−42.09K shares · No shares reported at quarter-end
Portfolio importance

How important is Thermo Fisher Scientific Inc in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.0%Q2 2026
Current rank#422of 997 reported positions
Peak portfolio weight0.4%Q3 2022
Best historical rank#35Q2 2012
At peak importanceQ3 2022
TMO
0.4%
Largest holding
4.2%
Cross-investor discovery

Who else owns Thermo Fisher Scientific Inc?

Also reported by 2 other tracked investors in their latest verified filings.

Stanley DruckenmillerDuquesne Family Office
TMO0.2% of reported portfolio
Joel GreenblattGotham Asset Management
TMO0.2% of reported portfolio
Explore Thermo Fisher Scientific Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$609.822026-09-11

Market context only; not an investor transaction price.

Latest filing quarter-end price$501.36Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$501.76Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.